Drug Trial Radar · NCT02197156
A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery
Last checked: Nov 19, 2026Latest source record: Nov 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
241
Actual
Start
Aug 2002
Primary completion
Feb 2003
Study completion Feb 2003
Sponsor
- Lead sponsor
- Zogenix, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 22, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to establish a dose-response relationship among several capsule strengths of Hydrocodone Bitartrate Extended Release (HC-ER) and to compare the efficacy to placebo following bunionectomy surgery
Conditions
- Postoperative Pain
Interventions
10 mg HC-ERDrug
Single dose
20 mg HC-ERDrug
Single dose
30 mg HC-ERDrug
Single dose
40 mg HC-ERDrug
Single dose
10 mg HC / 325 mg APAPDrug
Single dose
Matching PlaceboDrug
Single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Sum of Pain Intensity Differences (SPID) for the Visual Analog Scale Pain Intensity (VASPI)Time frame: 0-12 hours
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.